# EDGAR Filing Document

**Accession Number:** 0001866518
**File Stem:** 0001683168-23-000974
**Filing Date:** 2023-2
**Character Count:** 48588
**Document Hash:** 3a33e12da8c29fa9f142cd5d806836b6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-23-000974.hdr.sgml**: 20230216

**ACCESSION NUMBER**: 0001683168-23-000974

**CONFORMED SUBMISSION TYPE**: F-1/A

**PUBLIC DOCUMENT COUNT**: 8

**FILED AS OF DATE**: 20230216

**DATE AS OF CHANGE**: 20230216

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SolarJuice Co., Ltd.
- **CENTRAL INDEX KEY:** 0001866518
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** F-1/A
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-267486
- **FILM NUMBER:** 23638708

**BUSINESS ADDRESS:**
- **STREET 1:** 6950 PRESTON AVENUE
- **CITY:** LIVERMORE
- **STATE:** CA
- **ZIP:** 94551
- **BUSINESS PHONE:** 888-57S-1940

**MAIL ADDRESS:**
- **STREET 1:** 6950 PRESTON AVENUE
- **CITY:** LIVERMORE
- **STATE:** CA
- **ZIP:** 94551

***As filed with the Securities and Exchange Commission on February 16, 2023.***

**Registration No. 333-267486**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM F-1**

**(Amendment No. 6)**

**REGISTRATION STATEMENT**

**UNDER<br> THE SECURITIES ACT OF 1933**

**SOLARJUICE CO., LTD.**

*(Exact name of Registrant as specified in its charter)*

 

---

| | | |
|:---|:---|:---|
| **Cayman Islands**<br> *(State or other jurisdiction of*<br> *incorporation or organization)* | **4931**<br> *(Primary Standard Industrial<br> Classification Code Number)* | **Not Applicable**<br> *(I.R.S. Employer<br> Identification Number)* |

---

**1/10-12 Forsyth Close**

**Wetherill Park, Sydney, NSW, Australia**

**+61 2 9725 1111**

*(Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices)*

**Randolph Conone**

**Chief Financial Officer**

**4741 Urbani Avenue**

**McClellan Park, California 95652**

**888-575-1940**

*(Name, address, including zip code, and telephone number, including area code, of agent for service)*

**Copies to:**

---

| | |
|:---|:---|
| **Mitchell S. Nussbaum, Esq.**<br> **David J. Levine, Esq.**<br> **James A. Prestiano, Esq.**<br> **New York, New York 10154**<br> **Telephone: (212) 407-4000**<br> **Facsimile: (212) 407-4990**  | **M. Ali Panjwani, Esq.**<br> **Pryor Cashman LLP**<br> **7 Times Square**<br> **New York, New York 10036**<br> **Telephone: (212) 421-4100**<br> **Facsimile: (212) 326-0806** |

---

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ⌧

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ◻

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ◻

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ◻

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company ⌧

If an emerging growth company that prepares its financial statements in accordance with US GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ◻

† The term "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

**The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall hereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to such Section 8(a), may determine.**

**EXPLANATORY NOTE**

**This Amendment No. 6 to the Registration Statement on Form F-1 is being filed solely to include certain exhibits to the Registration Statement as indicated in the Exhibit Index contained in Part II of the Registration Statement.**

**PART II**

**INFORMATION NOT REQUIRED IN PROSPECTUS**

**Item 6.** ***Indemnification of Directors and Officers***

Cayman Islands law does not limit the extent to which a company's articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Memorandum and Articles of Association provide for indemnification of officers and directors for losses, damages, costs and expenses incurred in their capacities as such, except through their own actual fraud or willful default.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Registrant pursuant to the foregoing provisions, the Registrant has been informed that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

**Item 7.** ***Recent Sales of Unregistered Securities***

Set forth below is information regarding share capital issued by us during the last three years. None of the below described transactions involved any underwriters, underwriting discounts or commissions, or any public offering.

On February 16, 2017, 1 ordinary share, par value $1.00 per ordinary share, of our company was issued to SPI Investments Holding Limited.

On February 28, 2021, an option to purchase 6,000,000 fully vested ordinary shares at an exercise price of $0.48 per share was granted to LDK New Energy Holding Limited, an entity wholly owned by Mr. Peng's wife. Based on the one (1) share for four (4) share reverse stock split that occurred on July 6, 2022, such options have been reduced to 1,500,000 and the exercise price has been increased to $1.92.

On February 28, 2021, our authorized share capital was altered from $50,000 divided into 4,500,000,000 ordinary shares, par value $0.00001 per share and 500,000,000 Preferred Shares, par value $0.00001 per share, to 5,000,000,000 ordinary shares of par value $0.00001 per share. In connection with the alteration of share capital, we reclassified our 50,000,000 preferred shares issued as ordinary shares.

On May 14, 2021, our share capital $50,000 was divided into 4,500,000,000 ordinary shares, par value $0.00001 per share and 500,000,000 Preferred Shares, par value $0.00001 per share.

On May 14, 2021, pursuant to a subscription agreement by and between the Company and SPI Investments Holding Limited, SPI Investments Holding Limited subscribed for 99,900,000 ordinary shares, par value $0.00001 from us for a purchase price equal to the aggregate par value of the shares.

As a result of the subscription and the share capital division, 100,000,000 ordinary shares of our company were issued to SPI Investments Holding Limited. Our issued and outstanding ordinary shares were retrospectively adjusted to reflect such share capital division and the subscription from the first period presented, which were 100,000,000 shares with a par value of $0.00001 per share.

On May 17, 2021, options to purchase approximately 4,600,000 shares, subject to a four-year vesting schedule, was granted to approximately 80 employees as part of our employee stock purchase plan. Going forward we plan to continue to grant share options to our employees so that the majority of them will become a shareholder of the Company.

On June 7, 2021, we reclassified 500,000,000 preferred shares, par value $0.00001 per share, to 500,000,000 ordinary shares, par value $0.00001 per share. The authorized share capital of the Company was changed from US$50,000 divided into 4,500,000,000 ordinary shares of par value US$0.00001 per share and 500,000,000 preferred shares of par value US$0.00001 per share, to 5,000,000,000 ordinary shares of par value US$0.00001 each.

On July 6, 2022, each issued and unissued ordinary share of par value US$0.00001 per share was consolidated into 1 ordinary share of US$0.00004 each pursuant to a one (1) share for four (4) shares reverse stock split. As a result of the reverse stock split, the authorized share capital of the Company was changed from US$50,000 divided into 5,000,000,000 ordinary shares of par value US$0.00001 each, to US$50,000 divided into 1,250,000,000 ordinary shares of par value US$0.00004 each.

We believe that the offers, sales and issuance of the securities described in the preceding paragraph were exempt from registration either (a) under Section 4(a)(2) of the Securities Act and the rules and regulations promulgated thereunder, in that the transactions were between an issuer and sophisticated investors or members of its senior executive management and did not involve any public offering within the meaning of Section 4(a)(2), (b) under Regulation S promulgated under the Securities Act in that offers, sales and issuance were not made to persons in the United States and no directed selling efforts were made in the United States, or (c) under Rule 701 promulgated under the Securities Act in that the transactions were underwritten compensatory benefit plans or written compensatory contracts.

**Item 8.** ***Exhibits and Financial Statement Schedules***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Exhibits

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description of Document** |
| 1.1+ | [Form of Underwriting Agreement](https://www.sec.gov/Archives/edgar/data/1866518/000168316823000242/solarjuice_ex0101.htm) |
| 3.1+ | [Memorandum and Articles of Association of the Registrant, as currently in effect](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex0301.htm) |
| 3.2+ | [Form of Amended and Restated Memorandum and Articles of Association of the Registrant, to be effective upon the effectiveness of this offering](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex0302.htm) |
| 4.1+ | [Registrant's Specimen Certificate for Ordinary Shares](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex0401.htm) |
| 4.2+ | [Form of Representative's Warrant](https://www.sec.gov/Archives/edgar/data/1866518/000168316823000242/solarjuice_ex0402.htm) |
| 5.1\* | [Opinion of Carey Olsen Hong Kong LLP regarding the validity of the ordinary shares being registered](solarjuice_ex0501.htm) |
| 10.1+ | [Form of Independent Director Agreement between the Registrant and each of its directors](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex1001.htm) |
| 10.2+ | [Asset Purchase and Sale Agreement, dated February 5, 2021, between Petersen-Dean, Inc. and the other Debtors named therein and SolarJuice American, Inc.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex1002.htm) |
| 10.3+ | [Amended and Restated Invoice Purchase Agreement, dated as of February 24, 2021, between LS DE LLC, LSQ Funding Group L.C. and SolarJuice American Inc.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex1003.htm) |
| 10.4+ | [Lease Agreement, dated February 13, 2019, between Petersen-Dean, Inc. and Blue-Water Dupont, LLC.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex1004.htm) |
| 10.5+ | [Lease Agreement, dated March 1, 2021, between SolarJuice American, Inc. and Cranbrook Realty Investment Fund, L.P.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex1005.htm) |
| 10.6+ | [Lease Agreement, dated March 1, 2019, between Red Rose, Inc. dba PetersenDean Roofing Systems and 5050 Timbercreek, LLC.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex1006.htm) |
| 10.7+ | [Lease Agreement, dated August 1, 2018, between Solar Juice Pty Ltd and Carvet Pty Ltd.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex1007.htm) |
| 10.8+ | [Lease Agreement, dated August 1, 2018, between Solar Juice Pty Ltd and Carvet Pty Ltd.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006471/solar_ex1008.htm) |
| 10.9+ | [Sublease Agreement, dated October 13, 2022, between SPI Solar, Inc. and Solar4America Technology, Inc. for 125,190 square feet of space at Building 783, 4741 Urbani Avenue, McClellan, California 95652.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex1009.htm) |
| 10.10+ | [Sublease Agreement, dated October 13, 2022, between SPI Solar, Inc. and Solar4America Technology, Inc. for 139,100 square feet of space at Building 783, 4741 Urbani Avenue, McClellan, California 95652.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex1010.htm) |
| 10.11+ | [Sublease Agreement, dated October 13, 2022, between SPI Solar, Inc. and Solar4America Technology, Inc. for 56,000 square feet of space at Building 783, 4741 Urbani Avenue, McClellan, California 95652.](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex1011.htm) |

---

---

| | |
|:---|:---|
| 14+ | [Code of Business Conduct and Ethics](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex1400.htm) |
| 21.1+ | [List of Subsidiaries of the Registrant](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex2101.htm) |
| 23.1\* | [Consent of Marcum Asia CPAs LLP, Independent Registered Public Accounting Firm](solarjuice_ex2301.htm) |
| 23.2\* | [Consent of Carey Olsen Hong Kong LLP](solarjuice_ex0501.htm) (included in Exhibit 5.1) |
| 24.1+ | Powers of Attorney (included on signature page) |
| 99.1+ | [Audit Committee Charter](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex9901.htm) |
| 99.2 + | [Compensation Committee Charter](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex9902.htm) |
| 99.3 + | [Corporate Governance and Nominating Committee Charter](http://www.sec.gov/Archives/edgar/data/1866518/000168316822006908/solar_ex9903.htm) |
| 99.4+ | [Consent of Ken He, as independent director nominee](https://www.sec.gov/Archives/edgar/data/1866518/000168316823000242/solarjuice_ex9904.htm) |
| 99.5+ | [Consent of Dr. Philip Comberg, as independent director nominee](https://www.sec.gov/Archives/edgar/data/1866518/000168316823000242/solarjuice_ex9905.htm) |
| 99.6+ | [Consent of Yun Fei, as independent director nominee](https://www.sec.gov/Archives/edgar/data/1866518/000168316823000242/solarjuice_ex9906.htm) |
| 99.7+ | [SolarJuice Co., Ltd. February 13, 2023 Representation Letter pursuant to Instruction 2 to Item 8.A.4 of Form 20-F.](http://www.sec.gov/Archives/edgar/data/1866518/000168316823000821/solarjuice_ex9907.htm) |
| 107+ | [Filing Fee Table](http://www.sec.gov/Archives/edgar/data/1866518/000168316823000821/solarjuice_ex107.htm) |

---

_________________

\* Filed herewith.

+ Previously filed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Financial Statement Schedules

All schedules have been omitted since they are not required or are not applicable or the required information is shown in the financial statements or related notes.

**Item 9. *Undertakings***

The registrant hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) to include any prospectus required by Section 10(a)(3) of the Securities Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement.

Provided, however, that paragraphs (3)(i) and (3)(ii) of this section do not apply if the registration statement is on Form S-3, Form S-8 or Form F-3, and the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) to remove from registration by means of a post-effective amendment any of the securities being registered that remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) to file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Act or Rule 3-19 of this chapter if such financial statements and information are contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Form F-3.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) for purposes of determining any liability under the Securities Act, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8) for the purposes of determining liability to any purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9) for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities: The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in McClellan, California on February 16, 2023.

---

| | |
|:---|:---|
| **SOLARJUICE CO., LTD.** | **SOLARJUICE CO., LTD.** |
| By: | /s/ Hoong Khoeng Cheong |
| Name: | Hoong Khoeng Cheong |
| Title: | Chief Executive Officer |
| By: | /s/ Randolph Conone |
| Name: | Randolph Conone |
| Title: | Chief Financial Officer |

---

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:

---

| | | |
|:---|:---|:---|
| Dated: February 16, 2023 | By: | /s/ Hoong Khoeng Cheong |
|  | Name: | Hoong Khoeng Cheong |
|  | Title: | Chief Executive Officer and (Principal Executive Officer) |
| Dated: February 16, 2023 | By: | /s/ Randolph Conone |
|  | Name: | Randolph Conone |
|  | Title: | Chief Financial Officer (Principal Financial and Accounting Officer) |
| Dated: February 16, 2023 | By: | /s/ Xiaofeng Peng |
|  | Name: | Xiaofeng Peng |
|  | Title: | Director |

---

**SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES**

Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of SolarJuice Co., Ltd. has signed this registration statement or amendment thereto in New York, New York, United States of America on February 16, 2023.

---

| |
|:---|
| Authorized United States Representative |
| /s/ Randolph Conone |
| Randolph Conone |

---

## Exhibit 5.1

**Exhibit 5.1**

![](image_001.jpg)

---

| | | |
|:---|:---|:---|
| Our ref<br> Your ref | 1072974/0002/H336052v6<br>|  |
| **By Email** | **By Email** |  |
| SolarJuice Co., Ltd.<br> 1/10-12 Forsyth Close,<br> Wetherill Park,<br> Sydney, NSW<br> Australia | SolarJuice Co., Ltd.<br> 1/10-12 Forsyth Close,<br> Wetherill Park,<br> Sydney, NSW<br> Australia | 15 February 2023 |
| Dear Sir or Madam | Dear Sir or Madam |  |
| **SOLARJUICE CO., LTD. (the "Company")** | **SOLARJUICE CO., LTD. (the "Company")** | **SOLARJUICE CO., LTD. (the "Company")** |

---

We have acted as Cayman Islands legal counsel to the Company in connection with a registration statement on Form F-1, including all amendments or supplements thereto filed with the Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended (the "**Securities Act**"), initially filed on September 16, 2022 (the "**Registration Statement**", which term does not include any other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto), registering an aggregate of 3,450,000 ordinary shares of a par value of US$0.00004 each of the Company (the "**Ordinary Shares**"), which includes 450,000 Ordinary Shares subject to the underwriter's over-allotment option, for the offering and sale to the public by the Company.

This Opinion is given only on the laws of the Cayman Islands in force at the date hereof and is based solely on matters of fact known to us at the date hereof. We have not investigated the laws or regulations of any jurisdiction other than the Cayman Islands. We express no opinion as to matters of fact or, unless expressly stated otherwise, the veracity of any representations or warranties given in or in connection with any of the documents set out in Section 2.

In giving this Opinion we have reviewed originals, copies, drafts, and certified copies of the documents set out in Section 2. This Opinion is given on the basis that the assumptions set out in Section 3 (which we have not independently investigated or verified) and the Director's Certificate are true, complete and accurate in all respects. In addition, this Opinion is subject to the qualifications set out in Section 4. Capitalised terms used in this Opinion shall have the meanings ascribed to them in this Opinion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Opinions

We are of the opinion that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company has been duly incorporated as an exempted company with limited liability under the Companies
Act (as revised) of the Cayman Islands (the "**Companies Act**") and is validly existing. The Company has all requisite power
and authority, and all material governmental licenses, authorisations, consents and approvals that are required to own and operate its
properties and assets and to carry on its business as now conducted and as proposed to be conducted (all as described in the SEC Reports),
and the Company is duly qualified to transact business, in each case as required as a matter of Cayman Islands law.

(b) Based on our review of the Memorandum and Articles (as defined in Section 2), the authorised share capital
of the Company is US$50,000 divided into 1,250,000,000 Ordinary Shares.

(c) Upon the due issuance of the Ordinary Shares and payment of the consideration therefor as contemplated
in the Registration Statement, such Ordinary Shares will be validly issued, fully paid and non-assessable (which term means when used
herein that no further sums are required to be paid by the holders thereof in connection with the issue of such shares).

(d) The statements under the caption "Taxation" in the prospectus forming part of the Registration
Statement, to the extent that they constitute statements of Cayman Islands law, are accurate in all material respects and that such statements
constitute our opinion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Documents Reviewed

The documents listed in this Section 2 are the only documents and/or records we have examined and relied upon and the only searches and enquiries we have carried out for the purposes of this Opinion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The certificate of incorporation of the Company dated 16 February 2017, the amended and restated memorandum
and articles of association of the Company adopted on 7 June 2021 and the second amended and restated memorandum and articles of association
of the Company adopted on 6 July 2022 (collectively, the "**Memorandum and Articles** "), the Register of Directors, in each
case, of the Company, copies of which have been provided to us by the Company (together the "**Company Records** ").

(b) A director's certificate signed by a Director dated 13 February 2023, attached at Schedule 1 hereto (the
" **Director's Certificate** ").

(c) The written resolutions of the board of director of the Company (the "**Directors**") dated
15 July 2021 (the "**Resolutions** ").

(d) The Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Assumptions

****<br>We have assumed:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) that all necessary corporate action will be taken in accordance with applicable law and the Memorandum
and Articles to authorise and approve any issuance of, the terms of the offering thereof and related matters, and that the applicable
definitive purchase, underwriting or similar agreements in respect of such issuance (the "**Issuance Documents**") will be,
or have been, duly approved, executed and delivered by or on behalf of the Company and all other parties thereto;

(b) the authenticity, accuracy and completeness of all documents supplied to us, whether as originals or copies
and of all factual representations expressed in or implied by the documents we have examined;

(c) that where we have been provided with a document in executed form or with only the signature page of an
executed document, that such executed document does not differ from the latest draft version of the document provided to us and, where
a document has been reviewed by us in draft or specimen form, it will be or has been executed in the form of that draft or specimen;

(d) that each of the Issuance Documents constitutes legal, valid and binding obligations, enforceable in accordance
with its terms, of each party to the Issuance Documents under all laws other than, in the case of the Company, the laws of the Cayman
Islands;

(e) all authorisations, consents, filings, registrations or other requirements of governmental, judicial or
public bodies and authorities required under any law (including the laws of the Cayman Islands) for any party (other than under the laws
of the Cayman Islands, the Company) to execute, or deliver, or enforce the Issuance Documents or perform any of its obligations under
the Issuance Documents have been obtained, remain valid and subsisting and have been complied with;

(f) the choice of governing law in each of the Issuance Documents has been freely made in good faith (for
example not made with any intention of avoiding provisions of the law with which the transactions under the Issuance Documents have the
closest and most real connection) and, where such law is a law or regulation of any jurisdiction other than the Cayman Islands (collectively,
the "**Foreign Laws** "), would be regarded as a valid and binding selection, which will be upheld by the courts of such jurisdiction
as a matter of such governing law and all other laws (other than the laws of the Cayman Islands). There is no reason for avoiding that
choice of governing law on grounds of public policy or otherwise;

(g) none of the Proceeds of Crime Act (as revised) of the Cayman Islands relating to money laundering, the
Misuse of Drugs Act (as revised) of the Cayman Islands relating to drug trafficking or the Terrorism Act (as revised) of the Cayman Islands
relating to the financing of terrorism is relevant to the transactions contemplated by the Issuance Documents or to any payment made or
to be made thereunder;

(h) none of the parties to the Issuance Documents is acting, or will act in a matter inconsistent with United
Nations sanctions as implemented under the laws of the Cayman Islands or restrictive measures adopted by the European Union Council for
Common Foreign and Security Policy extended to the Cayman Islands by the Orders of Her Majesty in Council;

(i) all necessary consents have been given, actions taken (other than those required pursuant to the laws
of the Cayman Islands or the Memorandum and Articles) and conditions met or validly waived pursuant to the Issuance Documents;

(j) each of the parties has entered into the Issuance Documents in good faith for *bona fide* commercial
reasons and on arm's length terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) each of the Issuance Documents has not been amended, modified, supplemented, revoked, rescinded nor terminated
since the time of its execution;

(l) the Company has entered into the Issuance Documents as principal for its own account and not as agent
or fiduciary;

(m) in connection with the Company's entry into and performance of its obligations contained in the Issuance
Documents, each of its authorised representatives has acted in accordance with his fiduciary and other duties to the Company under all
relevant laws (including any relevant Foreign Laws) and the Memorandum and Articles (including in relation to any obligation to disclose
a conflict of interest in connection therewith);

(n) the Resolutions remain in full force and effect and have not been amended, modified, supplemented, revoked,
rescinded or terminated in any way, and any minutes are a true and correct record of the proceedings of the relevant meeting, which was
duly convened and held and at which a quorum was present throughout in the manner prescribed in the Memorandum and Articles;

(o) the Resolutions have been duly executed and the signatures and initials thereon are those of a person
or persons in whose name the Resolutions have been expressed to be signed;

(p) that the Memorandum and Articles will remain in full force and effect and will be unamended;

(q) the full power (including both capacity and authority), legal right and good standing of each of the parties
to the Issuance Documents to execute, date, unconditionally deliver and perform their obligations under the Issuance Documents;

(r) that the applicable Issuance Documents relating to any Ordinary Shares to be offered and sold will constitute
legal, valid and binding obligations, enforceable in accordance with their terms;

(s) that the issuance and sale of and payment for the Ordinary Shares will be in accordance with the applicable
Issuance Documents duly approved by the board of directors of the Company and/or where so required, the shareholders of the Company and
the Registration Statement (including the prospectus set forth therein and any applicable supplement thereto);

(t) that upon issue of any Ordinary Shares to be sold by the Company, the Company will receive consideration
for the full issue price thereof which shall be equal to at least the par value thereof;

(u) that the Company will issue the Ordinary Shares in furtherance of its objects as set out in its memorandum
of association;

(v) none of the Ordinary Shares has been or will be offered or issued to residents of the Cayman Islands;

(w) that no party is aware of any improper purpose for the issue of the Ordinary Shares;

(x) no law or regulation of any jurisdiction other than the Cayman Islands qualifies or affects this Opinion;
and

(y) the validity and binding effect under the laws of the United States of America of the Registration Statement
and that the Registration Statement will be duly filed with and declared effective by the Commission.

**4.** **Qualifications** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) we express no opinion in respect of the enforceability of any provision in the Registration Statement
and any applicable Issuance Documents which purports to fetter the statutory powers of the Company;

(b) the obligations under the Issuance Documents will not necessarily be legal, valid, binding or enforceable
in all circumstances and this Opinion is not to be taken to imply that each obligation would necessarily be capable of enforcement or
be enforced in all circumstances in accordance with its terms. In particular, but without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the binding effect, validity and enforceability of obligations may be
limited by laws relating to bankruptcy, administration, insolvency, moratorium, liquidation, dissolution, re-organisation and other laws
of general application relating to, or affecting the rights of, creditors;

(ii) enforcement may be limited by general principles of equity. For example,
equitable remedies such as specific performance or the issuing of an injunction are available only at the discretion of the court and
may not be available where, for example, damages are considered to be an adequate alternative and we therefore express no opinion on whether
such remedies will be granted if sought;

(iii) claims may be or become barred under the laws relating to the prescription
and limitation of actions or may become subject to the general doctrine of estoppel or waiver in relation to representations, acts or
omissions of any relevant party or may become subject to defences of set-off or counterclaim;

(iv) the courts of the Cayman Islands may not enforce contractual provisions
to the extent that the same may be illegal or contrary to public policy in the Cayman Islands (for example, a provision purporting to
indemnify or exculpate a person for an action which constitutes actual fraud or a criminal offence) or, if obligations are to be performed
in a jurisdiction outside the Cayman Islands, to the extent that such performance would be illegal or invalid or contrary to public policy
in that jurisdiction;

(v) a judgment of the courts of the Cayman Islands may be required to be
satisfied in Cayman Islands dollars;

(vi) the courts of the Cayman Islands have jurisdiction to give judgment
in the currency of the relevant obligation and statutory rates of interest will vary according to the currency of the judgment. In a liquidation
proceeding, the courts of the Cayman Islands will require all debts to be proved in a common currency, which is likely to be the "functional
currency" of the party being liquidated determined in accordance with applicable accountancy principles. Currency indemnity provisions
have not been tested, so far as we are aware, in the courts of the Cayman Islands and as such may not be enforceable;

(vii) the courts of the Cayman Islands may decline to accept jurisdiction
in an action where they determine that there is another more appropriate forum in another jurisdiction or that a court of competent jurisdiction
has already made a determination of the relevant matter or where there is litigation pending in respect thereof in another jurisdiction
or it may stay proceedings if concurrent proceedings are instituted elsewhere;

(viii) there is a presumption that the courts of the Cayman Islands will give
effect to an exclusive jurisdiction clause in an agreement and upon application, may stay proceedings brought in the Cayman Islands or
grant an anti-suit injunction against a party that commences proceedings elsewhere where such proceedings are in breach of the exclusive
jurisdiction clause, unless a party can satisfy the courts of the Cayman Islands that it would be just and equitable to depart from that
presumption (for example, not to do so would deprive one party of access to justice);

(ix) any provision purporting to fetter any statutory power of a Cayman Islands
partnership or company (for example, a provision restricting the company's power to commence winding up, to alter its memorandum and articles
of association or to increase its share capital) may not be enforceable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) provisions that purport to require parties to reach agreement in the
future may be unenforceable for lack of certainty;

(xi) the courts of the Cayman Islands may find that a hybrid dispute resolution
clause, though generally recognised under Cayman Islands law, is unenforceable on the grounds, amongst others, that it confers concurrent
jurisdiction on an arbitral tribunal and the courts of the Cayman Islands;

(xii) the courts of the Cayman Islands may refuse to enforce a provision that
amounts to an indemnity in respect of the costs of enforcement or of unsuccessful proceedings brought in the Cayman Islands where such
courts have already made an order to that effect;

(xiii) where the courts of the Cayman Islands determine that a contractual
term may be interpreted in more than one manner the courts may employ the one that is deemed to be most consistent with business and common
sense;

(xiv) it is possible that a judgment (in the Cayman Islands or elsewhere)
relating to a particular agreement or instrument would be held to supersede the terms of such agreement or instrument with the effect
that, notwithstanding any express term to the contrary in such agreement or instrument, such terms would cease to be binding;

(xv) the enforcement of contractual obligations may be limited by the provisions
of Cayman Islands law applicable to agreements or contracts held to have been frustrated by events happening after the relevant agreement
or contract was entered into; and

(xvi) the enforcement of obligations may be invalidated or vitiated by reason
of fraud, duress, undue influence, mistake, illegality or misrepresentation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) notwithstanding a valid choice of law provision, the courts of the Cayman Islands may refuse to apply
the relevant governing law, for example, (i) if it is not pleaded and proved; (ii) if to do so would be contrary to the public policy
of the Cayman Islands; or (iii) in relation to laws that are mandatory in the relevant forum or which may not be derogated from contractually;

(d) we offer no opinion as to whether the acceptance of, or the execution or performance of, the Company's
obligations under the Issuance Documents will or may result in the breach or infringement of any other deed, contract or document entered
into by, or binding upon, the Company (other than the Memorandum and Articles);

(e) the question of whether or not any provision of an agreement or document which is illegal, invalid, unenforceable
or void may be severed from the other provisions thereof would be determined by the courts of the Cayman Islands in its discretion;

(f) we make no comment on references to any Foreign Laws or to any representations or warranties made in any
agreement or document; and

(g) we express no opinion on any provision in any agreement or document requiring written amendments and waivers
thereof insofar as it suggests that all or other modifications, amendments or waivers could not be effectively agreed upon or granted
by or between the parties. It is likely that the provisions of an agreement or document governed by Cayman Islands law may be waived or
amended orally or by conduct notwithstanding any such provision.

We are furnishing this Opinion as exhibit 5.1 of the Registration Statement. We hereby consent to the use of this Opinion in, and the filing hereof as an exhibit to, the Registration Statement and further consent to the reference of our name under the headings "Enforceability of Civil Liabilities and "Legal Matters" and elsewhere in the prospectus included in the Registration Statement. In giving this consent, we do not hereby admit that we are experts within the meaning of Section 11 of the Securities Act or that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission promulgated thereunder.

This Opinion (and any obligations arising out of or in connection with it) is given on the basis that it shall be governed by and construed in accordance with the laws of the Cayman Islands.

Yours faithfully

![Text, letter Description automatically generated](image_001.gif)

**Carey Olsen Hong Kong LLP**

**Schedule 1**

**Director's Certificate**

![](image_002.jpg)

Page 10 / 15 February 2023 1072974/0002/H336052v6

![](image_003.jpg)

Page 11 / 15 February 2023 1072974/0002/H336052v6

## Exhibit 23.1

**Exhibit 23.1**

![](image_007.jpg)

<u>Independent Registered Public Accounting Firm's Consent</u>

We consent to the inclusion in this Registration Statement of SolarJuice Co., Ltd. on Amendment No. 6 to the Form F-1, file No. 333-267486 of our report dated July 18, 2022, which includes an explanatory paragraph as to the Company's ability to continue as a going concern, with respect to our audits of the consolidated financial statements of SolarJuice Co., Ltd. as of December 31, 2021 and 2020 and for the years ended December 31, 2021 and 2020, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading "Experts" in such Prospectus.

/s/ Marcum Asia CPAs LLP

Marcum Asia CPAs LLP

New York, NY

February 15, 2023